Ebit 変化する 日付
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Astellas Pharma JPY 48.57B 85.97B 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Charles River Laboratories USD 75.82M 57.98M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Moderna USD -1.39B 531M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 4.62M 1.43M 2026-03
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12